Spero Therapeutics Inc (SPRO) has released an update to notify the public and investors about its officers.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Tamara Joseph is resigning as Chief Legal Officer and Corporate Secretary of Spero Therapeutics to explore new opportunities, effective March 6, 2024. She will receive severance pay and a pro-rated bonus totaling approximately $390,565.73, with ongoing benefits including consulting at $395 per hour for nine months and continued vesting of her stock options and RSUs. Spero’s CEO, Sath Shukla, expressed gratitude for her contributions and best wishes for her future. Details of her separation and consulting agreements will be disclosed in the company’s annual report.
For further insights into SPRO corporate activity, check out TipRanks’ Insiders Trading Activity page.
For a comprehensive understanding of the announcement, you can read the full document here.
